For CHIP-positive patients with NSCLC, hepatobiliary cancer, and renal cell carcinoma, more than 35% of metastatic samples analyzed exhibited TI-CH (Fig S22). The gene discussed is STUB1; the disease is hereditary clear cell renal cell carcinoma.